Showing 1471-1480 of 2105 results for "".
- Leaving AEDs Behind: When to Withdraw Therapy in Seizure-free Patientshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn1008_04-pdf/30980/Managing Antiepileptic Drug (AED) Therapy in Seizure-Free Patients: Key ConsiderationsAchieving complete seizure control is the primary objective in epilepsy management, significantly improving patient quality of life. In specific epilepsy syndromes, such as benign rolandic epilepsy (childhood epile
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31004/Malignant Hyperthermia: Clinical Insights and ManagementMalignant hyperthermia (MH) is a rare, life-threatening hypermetabolic neuromuscular disorder predominantly triggered by specific anesthetic agents in susceptible individuals, often presenting during general anesthesia. A notable case involved
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0608Dementia-pdf/31012/Current Alzheimer’s disease (AD) research predominantly targets the reduction and elimination of beta-amyloid 42 and phosphorylated Tau proteins, aiming to develop disease-modifying treatments. These pathological markers are critical in the onset and progression of AD, and intervening in their pathw
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31022/Advancements in Transient Ischemic Attack Management: Insights from the FASTER StudyRecent research published in Practical Neurology highlights critical findings from the Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER) study. This pilot clinical trial inv
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31040/In the March 2008 issue of *Practical Neurology*, Editor-in-Chief Jack Persico delves into the critical debate of experience versus expertise within the medical field. Drawing parallels from the political arena, specifically the 2008 Democratic primary race where candidates like Hillary Clinton emph
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31052/Wernicke Encephalopathy: Recognizing and Managing Thiamine Deficiency in Clinical PracticeWernicke encephalopathy (WE) remains a critical neurological emergency, predominantly affecting individuals with chronic alcoholism but also seen in various other conditions such as malignancies, bariatric surg
- The Fine Art of Managing Peripheral Nerve Injurieshttps://practicalneurology.com/columns/practice-management/the-fine-art-of-managing-peripheral-nerve-injuries/31102/Peripheral nerve injuries present a complex challenge in neurology, requiring precise diagnosis and tailored management to optimize patient outcomes. These injuries are broadly classified into two categories: transection and neuroma-in-continuity. Transection involves a complete severance of the ner
- The Age Obstruction? Considering CEA in the Advanced Elderlyhttps://practicalneurology.com/columns/practice-management/the-age-obstruction-considering-cea-in-the-advanced-elderly/31097/Evaluating Surgical Interventions for Carotid Stenosis in the Advanced ElderlyAs the population of Americans aged 85 and older rapidly increases, healthcare professionals face significant challenges in managing carotid stenosis within this demographic. Carotid stenosis, characterized by the narrowin
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31119/Innovative Approaches to Managing Menstrual Migraine: Expert InsightsRecent advancements in the prophylactic treatment of menstrual migraine highlight the potential of off-label Naratriptan use. A study published in *Headache* demonstrates that administering 1 mg of Naratriptan twice daily, suppleme
- Moving Past Conventional Wisdom in AD Therapyhttps://practicalneurology.com/columns/practice-management/moving-past-conventional-wisdom-in-ad-therapy/31124/Recent advancements in Alzheimer's Disease (AD) treatment are unveiling innovative approaches beyond traditional methods, as highlighted in Practical Neurology's latest News Briefs. Baxter International has reported promising outcomes from its phase II trial of gammagard IVIg, an immunomodulatory th